A widely used class of stomach acid drugs called “Proton pump inhibitors” (PPIs) have been associated with an increased risk for chronic kidney disease, according to two population-based analyses published in JAMA Internal Medicine in January 2016.
An estimated 15 million Americans take PPI drugs, which reduce the production of acid made by the stomach glands. These drugs are typically taken to treat gastroesophageal reflux disease (GERD), peptic or stomach ulcers, and damage to the lower esophagus caused by acid reflux.
PPIs, which are both prescribed and purchased over-the-counter, are well-known and include brand names such as:
Chronic kidney disease involves the gradual loss of kidney function. The condition can progress to end-stage kidney failure, which is fatal unless a patient undergoes dialysis or a kidney transplant.
Contact our firm for assistance if you took a PPI drug over an extended period of time and are suffering from severe kidney disease. We can investigate your situation and answer any legal questions you have.